From the case: Glioblastoma IDH wild-type (thalamic with pseudoprogression)
- “ Pseudoprogression is typically encountered in the first 6 months following completion of radiotherapy and is particularly common in MGMT methylate...”
Updating… Please wait.
Unable to process the form. Check for errors and try again.
Thank you for updating your details.